Sökning: onr:"swepub:oai:DiVA.org:uu-150716" >
Achievement of reco...
Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol : An observational study
-
- Fernström, Anders (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Njurmedicinska kliniken US,Njurmedicin
-
- Giaever, Jan (författare)
- Karolinska University
-
- Granroth, Barbara (författare)
- Sundsvall Hospital
-
visa fler...
-
- Hylander, Britta (författare)
- Karolinska Institutet,Karolinska University
-
- Jensen, Gert (författare)
- Sahlgrenska University
-
- Christensson, Anders (författare)
- Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups,Malmo University Hospital
-
- Wikström, Björn (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Akad University
-
- Weiss, Lars (författare)
- Karlstad Hospital
-
- Wrege, Ulf (författare)
- Gavle Cent Hospital
-
- Jacobson, Stefan H. (författare)
- Karolinska Institutet,Danderyd Hospital
-
visa färre...
-
(creator_code:org_t)
- 2011-03-02
- 2011
- Engelska.
-
Ingår i: Scandinavian Journal of Urology and Nephrology. - : Informa UK Limited. - 0036-5599 .- 1651-2065. ; 45:3, s. 196-205
- Relaterad länk:
-
https://lup.lub.lu.s...
-
visa fler...
-
https://portal.resea... (primary) (free)
-
http://dx.doi.org/10...
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
https://lup.lub.lu.s...
-
http://kipublication...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective. Secondary hyperparathyroidism (SHPT) is a common problem among patients with chronic kidney disease (CKD) on haemodialysis. This study was conducted to assess the use, effectiveness and safety of intravenous paricalcitol in haemodialysis patients with various degrees of SHPT. Material and methods. This observational, multicentre, prospective study was conducted in 14 Swedish dialysis centres from May 2007 to June 2008 and included 92 haemodialysis patients with a diagnosis of SHPT associated with CKD. The decision to initiate treatment with intravenous paricalcitol was made by the treating physician. No treatment algorithms were provided. Results. Mean patient age was 64 years. Of the 92 patients included, 74 had an intact parathyroid hormone (iPTH) level of > 300 pg/ml at baseline. Median iPTH was 584 pg/ml in patients with a baseline PTH of > 300 pg/ml. During follow-up there was a decrease in iPTH to 323 pg/ml at 6 months (--45%, p < 0.0001). In parallel, there was a small increase in serum calcium, but serum phosphorus and the calcium xx phosphorus product remained unchanged. Conclusions. This study showed that intravenous paricalcitol substantially and safely decreased iPTH in haemodialysis patients with a baseline iPTH above the Kidney Disease Outcomes Quality Initiative recommended target range (150--300 pg/ml) and had minimal impact on serum minerals.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Annan klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Other Clinical Medicine (hsv//eng)
Nyckelord
- Dose titration
- paricalcitol
- SHPT
- MEDICINE
- MEDICIN
- Dose titration
- paricalcitol
- SHPT
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Fernström, Ander ...
-
Giaever, Jan
-
Granroth, Barbar ...
-
Hylander, Britta
-
Jensen, Gert
-
Christensson, An ...
-
visa fler...
-
Wikström, Björn
-
Weiss, Lars
-
Wrege, Ulf
-
Jacobson, Stefan ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Annan klinisk me ...
- Artiklar i publikationen
-
Scandinavian Jou ...
- Av lärosätet
-
Uppsala universitet
-
Lunds universitet
-
Karolinska Institutet
-
Linköpings universitet